Skip to main content
OpenTrials

Clinical trial condition

Metastatic Bladder Urothelial Carcinoma

Explore clinical trials studying Metastatic Bladder Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

16 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Bladder Urothelial Carcinoma trial results

Active, Not Recruiting

Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy

NCT04963153

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +36 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy

NCT04637594

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Bladder Urothelial Carcinoma, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 377 locations
View Trial Details

Related conditions